DOD-CDMRP: Prostate Cancer Research Program - Exploration - Hypothesis Development Award

The PCRP supports the exploration of highly innovative, untested, potentially groundbreaking concepts in PC. Emphasis is on innovation; potential impact may be unknown. Human subject  studies are permitted provided the studies are exempt or eligible for expedited review. Preliminary data are strongly discouraged. Funding: $75K over 1 year.

All applications for PCRP funding opportunities should also address at least one of 6 PCRP focus areas:
 - Biomarkers: Discovery and validation of biomarkers for the detection, prediction of response to therapy, prognosis,  and progression of PC.
 - Genetics: Understanding the genetics and epigenetics responsible for susceptibility, disease progression, and  treatment outcomes for clinically significant PC.
 - Imaging: Development of new anatomic and molecular imaging technology for the detection and management of PC.
 - Survivorship: Studies on the impact of treatment, nutrition, metabolism, and exercise on the well-being of PC patients and their families.
 - Therapy: Identification of new targets, pathways, and therapeutic modalities, including immunotherapy and mechanisms of resistance.
 - Tumor Biology and Immunology: Understanding prognosis and progression of PC.

Each PCRP funding opportunity either requires or encourages applications to address one of the following PCRPoverarching challenges:
- Develop effective treatments for advanced PC (i.e. disease relapse with no available curative therapy);
- Distinguish aggressive from indolent disease.